tiprankstipranks
Trending News
More News >
Swiss Re AG (CH:SREN)
:SREN
Advertisement

Swiss Re AG (SREN) AI Stock Analysis

Compare
16 Followers

Top Page

CH:SREN

Swiss Re AG

(OTC:SREN)

Rating:70Outperform
Price Target:
CHF157.00
▲(10.84% Upside)
Swiss Re AG's overall stock score of 70 reflects its strong financial performance and positive earnings call, which highlight improved profitability and robust capital strength. However, technical indicators suggest a bearish trend, and challenges in revenue growth and casualty volumes pose risks. The fair valuation and attractive dividend yield provide some support to the stock's appeal.

Swiss Re AG (SREN) vs. iShares MSCI Switzerland ETF (EWL)

Swiss Re AG Business Overview & Revenue Model

Company DescriptionSwiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. The Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland.
How the Company Makes MoneySwiss Re AG generates revenue primarily through the premiums it receives from insurance companies and other clients for providing reinsurance coverage. The company operates on a global scale, spreading risk by underwriting policies in multiple markets and industries. Key revenue streams include property and casualty reinsurance, which covers risks related to natural disasters, accidents, and liability issues, and life and health reinsurance, which manages mortality and morbidity risks. Swiss Re also earns income through investment activities, leveraging its capital to invest in various asset classes. Significant partnerships with insurance companies and corporations, along with its expertise in risk assessment and management, contribute to its earnings by enabling Swiss Re to craft tailored reinsurance solutions that address complex risk scenarios.

Swiss Re AG Earnings Call Summary

Earnings Call Date:Aug 14, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 14, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted Swiss Re's strong net income and ROE, improved P&C performance, disciplined pricing, and solid investment results. However, these positives were counterbalanced by declines in insurance revenue, challenges in casualty volumes, and negative experience variance in Life & Health Re. Overall, the highlights and lowlights appear balanced.
Q2-2025 Updates
Positive Updates
Strong Net Income and ROE
Swiss Re reported a net income of USD 2.6 billion for the first half of 2025, resulting in an annualized ROE of 23%. This achievement represents approximately 60% of their full-year net income target of more than USD 4.4 billion.
P&C Business Performance
The P&C businesses benefited from a relatively quiet second quarter in terms of large losses, leading to a strong combined ratio. The P&C reserves were bolstered by a USD 300 million nominal reserving in the first half.
Renewals and Pricing Discipline
The company achieved nominal price increases of 2.3% on its overall portfolio during midyear renewals, with significant increases in property and specialty lines, while reducing casualty volumes by 27%.
Life & Health Re Performance
Life & Health Re reported a net income of USD 839 million, slightly above its pro rata target. The largest portfolios, including U.S. mortality, performed in line with expectations.
Investment Results
The company achieved a return on investment (ROI) of 4.1% in the first half, slightly ahead of last year's 4%, with recurring income standing at USD 2 billion.
Capital Strength
Swiss Re's group SST ratio was estimated at 264% as of July 1, 2025, which is 7 points higher than at the start of the year.
Negative Updates
Decline in Group's Insurance Revenue
The group's insurance revenue amounted to USD 20.9 billion in the first half of 2025, down from USD 22.2 billion last year, driven by factors such as the termination of an external retrocession transaction and nonrenewal of certain businesses.
Life & Health Re Experience Variance
The Life & Health Re segment experienced a negative variance of USD 197 million in the first half due to selective assumption updates in onerous business and volume updates, although actual claims experience was slightly positive.
Challenges in Casualty Volume
Casualty volumes were significantly reduced by 27% due to challenges in achieving rate adequacy and risk assessment.
Company Guidance
During Swiss Re's Half Year 2025 Results Conference Call, the company reported a strong net income of USD 2.6 billion for the first half of the year, achieving an annualized ROE of 23%. The progress is attributed to a robust underwriting performance, particularly in the Property & Casualty (P&C) sector, which saw moderate large losses of under USD 150 million in Q2, predominantly from man-made events. This has led to a 60% realization of their USD 4.4 billion full-year net income target. The P&C Re unit posted a new business CSM of USD 2.2 billion, maintaining the same level as the previous year, and a combined ratio of 81.1%, well below their 85% target. Meanwhile, the Life & Health Re unit generated a net income of USD 839 million, slightly surpassing its pro-rata target. Despite facing challenges in some smaller portfolios, the unit remains on track. The company also reported a modest 3% year-to-date volume growth, with a net price change of negative 1.8%, and aims to reduce its cost run rate by USD 100 million this year, contributing to an overall target of USD 300 million by 2027. The group maintains an SST ratio of 264% as of July 1, 2025, reflecting a resilient capital position.

Swiss Re AG Financial Statement Overview

Summary
Swiss Re AG demonstrates robust financial health with a solid balance sheet and improving profitability. The company has managed to enhance its profitability and leverage. However, inconsistent revenue growth and the need for improved cash flow management and investment utilization are key challenges.
Income Statement
75
Positive
Swiss Re AG has shown a stable revenue base with some fluctuations over the years. The net profit margin improved to 37.14% in 2024 from 6.46% in 2023, indicating enhanced profitability. However, revenue decreased significantly from 2023 to 2024. EBIT margins have been inconsistent, with EBIT in 2024 being zero. The overall trend shows recovery from previous losses, yet maintaining consistent revenue growth remains a challenge.
Balance Sheet
80
Positive
The company's debt-to-equity ratio has improved over time, showing better leverage management, with a ratio of 0.31 in 2024. The equity ratio has remained stable, indicating a strong balance sheet. Return on Equity (ROE) increased significantly to 14.03% in 2024, highlighting improved shareholder returns. The financial stability is evident, but attention to asset management is needed due to fluctuating total assets.
Cash Flow
70
Positive
Operating cash flow showed a decline from 2023 to 2024, but free cash flow remained positive. The free cash flow to net income ratio improved, indicating better cash generation relative to profit. However, negative investing cash flow suggests a need for careful investment management. The cash flow situation is stable, but there is room for improvement in operational efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue49.82B8.72B49.73B46.04B46.74B43.34B
Gross Profit49.46B8.72B49.46B46.04B46.74B43.34B
EBITDA-593.00M4.27B-23.00M1.64B-573.00M115.00M
Net Income3.21B3.24B3.21B472.00M1.44B-878.00M
Balance Sheet
Total Assets179.58B127.23B179.58B170.68B181.57B182.62B
Cash, Cash Equivalents and Short-Term Investments88.38B88.64B88.38B85.61B4.15B4.70B
Total Debt9.82B7.26B9.82B11.04B11.19B11.74B
Total Liabilities163.21B103.99B163.21B157.87B10.32B11.58B
Stockholders Equity16.15B23.11B16.15B12.70B23.57B27.14B
Cash Flow
Free Cash Flow4.09B3.13B4.09B2.93B4.10B5.39B
Operating Cash Flow4.09B3.13B4.09B2.93B4.10B5.39B
Investing Cash Flow-362.00M-407.00M-362.00M-2.34B-2.14B-7.72B
Financing Cash Flow-3.22B-2.97B-3.22B-1.24B-2.10B-2.50B

Swiss Re AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price141.65
Price Trends
50DMA
144.62
Negative
100DMA
144.16
Negative
200DMA
138.40
Positive
Market Momentum
MACD
-1.34
Positive
RSI
41.46
Neutral
STOCH
33.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SREN, the sentiment is Negative. The current price of 141.65 is below the 20-day moving average (MA) of 144.79, below the 50-day MA of 144.62, and above the 200-day MA of 138.40, indicating a neutral trend. The MACD of -1.34 indicates Positive momentum. The RSI at 41.46 is Neutral, neither overbought nor oversold. The STOCH value of 33.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:SREN.

Swiss Re AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$38.29B12.9017.22%4.21%-4.94%
68
Neutral
$17.78B11.949.89%3.74%9.69%1.17%
65
Neutral
CHF9.07B23.69
4.06%-4.03%60.24%
57
Neutral
CHF10.54B19.25
3.42%-1.57%95.56%
$29.80B22.0217.11%4.20%
$102.24B18.2323.97%4.53%
€1.98B12.316.06%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:SREN
Swiss Re AG
141.65
31.18
28.23%
CH:BALN
Baloise Holding AG
199.10
43.95
28.33%
CH:HELN
Helvetia Holding AG
197.20
67.55
52.10%
SWSDF
Swiss Life Holding AG
1,058.32
267.49
33.82%
ZFSVF
Zurich Insurance Group
750.15
190.83
34.12%
DE:VAHB
Vaudoise Assurances Holding SA
674.00
247.08
57.88%

Swiss Re AG Corporate Events

Swiss Re Reports Record Insured Losses from Natural Disasters in 2025
Aug 6, 2025

Swiss Re Institute reports that insured losses from natural disasters in the first half of 2025 reached $80 billion, driven by record-breaking wildfires in California and severe thunderstorms in the USA. This figure is nearly double the ten-year average and suggests that total losses for the year could surpass the $150 billion forecast. The increase in losses is attributed to factors such as rising temperatures, more frequent droughts, and urban expansion into high-risk areas. The report underscores the importance of enhanced damage mitigation and adaptation measures to increase community resilience.

The most recent analyst rating on (CH:SREN) stock is a Hold with a CHF132.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

US Tariffs Impact Global Economic and Insurance Growth, Says Swiss Re
Jul 9, 2025

Swiss Re Institute reports that US tariffs are expected to slow global economic growth, impacting insurance premium growth rates. The tariffs are causing political uncertainty and trade difficulties, leading to a decrease in consumer spending and investment. This slowdown is expected to affect the insurance industry, with global premium growth predicted to decline. However, insurers’ profitability outlook remains positive due to rising capital returns. The US motor vehicle insurance sector is particularly affected by increased claims costs due to tariffs. Despite these challenges, opportunities exist in areas like credit and surety insurance, and transport insurance outside the US may benefit from supply chain reorganization.

The most recent analyst rating on (CH:SREN) stock is a Hold with a CHF132.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Swiss Re’s SONAR 2025 Report Highlights Extreme Heat as a Major Emerging Risk
Jun 12, 2025

Swiss Re’s 2025 SONAR report highlights extreme heat as a significant emerging risk, surpassing the combined fatalities from floods, earthquakes, and hurricanes. The report emphasizes the broad impact of extreme heat on human health, infrastructure, agriculture, and various industries, including energy and telecommunications. It also addresses the growing challenges posed by artificial intelligence incidents and declining trust in institutions, urging insurers to adapt to these evolving risks.

The most recent analyst rating on (CH:SREN) stock is a Hold with a CHF132.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Swiss Re Reports Strong Q1 2025 Profit Amid Challenges
May 16, 2025

Swiss Re reported a profit of USD 1.3 billion and a return on equity of 22.4% for the first quarter of 2025, driven by strong performances across its business segments despite significant losses from natural and man-made disasters. The company’s robust capital position and strategic actions, including successful contract renewals and portfolio management, have reinforced its market position and ability to support clients, while also planning to cancel excess shares to optimize capital structure.

The most recent analyst rating on (CH:SREN) stock is a Buy with a CHF122.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 02, 2025